Truepoint Q4 2022 vs. Q1 2023: A Comprehensive Review of Holdings

The 13F form, filed quarterly by institutional investors with at least $100 million in assets, provides insights into their holdings. Truepoint, Inc.'s 13F filings for Q4 2022 and Q1 2023 showed that the firm's assets under management increased from $1.7 billion to $1.8 billion. This blog post dives into the changes made by Truepoint, Inc. in their holdings and analyzes the reasons behind those decisions.

Firstly, let's look at the new additions. In Q1 2023, Truepoint, Inc. added positions in META Platforms Inc., Accenture plc Ireland, and United States Oil Fund LP. META Platforms is an online platform offering digital communities, while Accenture is a multinational professional services company. USO, on the other hand, is an oil fund that has seen its share price decline in recent years, which may have made it an attractive buy for Truepoint, Inc.

Moving on to the increased positions, the Dimensional ETF Trust was the standout holding for Truepoint, Inc. At the end of Q4 2022, the firm held 9,307,605 shares valued at $386,451,000 in the Dimensional ETF Trust. By the end of Q1 2023, Truepoint, Inc. had increased its position to 9,546,037 shares valued at $405,706,000. This represents an increase of 2.5% in position and 5% in value, indicating a strong conviction in the assets within the trust.

Other holdings with notable increases include CVS Health Corp, which saw Truepoint, Inc. increase its position by 42.4% in terms of shares and 38% in value. Procter & Gamble Co also saw a 5.8% increase in the number of shares held by the firm.

On the other hand, there were also holdings that Truepoint, Inc. reduced its position on. Notably, the firm reduced its position in Dimensional ETF Trust's DFUV by 19.6%. This holding saw a decrease in value from $86,714,000 to $69,749,000. This may suggest the firm's lack of confidence in the asset's long-term potential.

Another significant reduction was in Vanguard Municipal Bond Funds (BND), where Truepoint, Inc. reduced its position by 55.8% in terms of shares held and 52.7% in value held. The firm sold a total of 175,160 shares, equivalent to a value of $1,230,000, which may have been due to a change in market conditions or alternative investment opportunities.

It is worth noting that some holdings remained unchanged in terms of the number of shares held by Truepoint, Inc. These include the SPDR Dow Jones Industrial Average ETF Trust (DIA), in which Truepoint, Inc. held 13,107 shares, and Microsoft Corp (MSFT), in which the firm held 5,304 shares.

In conclusion, Truepoint, Inc.'s 13F filings for Q4 2022 and Q1 2023 showed both quantitative and qualitative changes. The firm's increased position in assets like Dimensional ETF Trust, CVS Health Corp, and Procter & Gamble Co may suggest strong conviction in the assets' long-term potential. Conversely, reductions in holdings of assets like DFUV and BND may indicate a lack of confidence in those holdings. As with all investment decisions, it is important to do thorough research before making any decisions based on the 13F filings of any firm.